Apyx Medical (APYX) Cash from Operations (2011 - 2026)
Apyx Medical (APYX) posted Cash from Operations of 572000.0 for Q1 2026, up 77.38% on a QoQ basis from 2529000.0 in Q4 2025, and up 18.52% year-over-year from 482625.0 in Q1 2025.
Apyx Medical (APYX) Cash from Operations (2011 - 2026) Analysis & Trends
Apyx Medical's Cash from Operations history runs 16 years deep, the most recent figure standing at 572000.0 for Q1 2026.
- Quarterly Cash from Operations rose 18.52% year-over-year to 572000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7870000.0 (up 36.57% YoY) and the FY2025 annual result came in at 8000000.0, up 55.67% from the prior year.
- Cash from Operations was 572000.0 for Q1 2026 at Apyx Medical, up from 2529000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3696000.0 in Q3 2023 and bottomed at 6341000.0 in Q1 2024.
- A 5-year average of 3067529.41 and a median of 3536000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 2216.82% — and 2023, when it jumped 168.96%.
- Apyx Medical's Cash from Operations stood at 4530000.0 in 2022, then soared by 51.17% to 2212000.0 in 2023, then plunged by 32.78% to 2937000.0 in 2024, then grew by 13.89% to 2529000.0 in 2025, then jumped by 77.38% to 572000.0 in 2026.
- Business Quant data shows APYX's Cash from Operations at 572000.0 in Q1 2026, 2529000.0 in Q4 2025, and 3536000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Apyx Medical | 167.53 Mn | 136.65 Mn | 7.93 Mn | -572,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -572,000.00 |
| Mar 31, 2026 | -572,000.00 |
| Dec 31, 2025 | -2.53 Mn |
| Dec 31, 2025 | -2.53 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -702,000.00 |
| Mar 31, 2025 | -702,000.00 |
| Dec 31, 2024 | -2.94 Mn |
| Dec 31, 2024 | -2.94 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -6.34 Mn |
| Mar 31, 2024 | -6.34 Mn |
| Dec 31, 2023 | -2.21 Mn |
| Dec 31, 2023 | -2.21 Mn |